Evidence map›Paper›PMID 36980439›Full record

ArticleDiagnostics (Basel, Switzerland)2023

The Malignant Gastrointestinal Neuroectodermal Tumor (GNET): A Distinct Entity and the Challenging Differential Diagnosis with Mesenchymal, Lymphoid, and Melanic Tumors: A Case Report and Brief Review of the Literature.

Mădălina Boșoteanu, Miruna Cristian, Mariana Așchie, Radu Andrei Baz, Alina Marta Zielonka, Georgeta Camelia Cozaru, Luana Andreea Boșoteanu

Open access · goldFull text readCase Reports
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mădălina BoșoteanuFaculty of Medicine, "Ovidius" University of Constanta, 900470 Constanta, Romania.
Miruna CristianFaculty of Medicine, "Ovidius" University of Constanta, 900470 Constanta, Romania.ORCID 0000-0001-5191-2585
Mariana AșchieDepartment of Clinical Pathology, "Sf. Apostol Andrei" Emergency County Hospital, 900591 Constanta, Romania.
Radu Andrei BazFaculty of Medicine, "Ovidius" University of Constanta, 900470 Constanta, Romania.
Alina Marta ZielonkaClinica Sante, 060754 Bucharest, Romania.
Georgeta Camelia CozaruDepartment of Clinical Pathology, "Sf. Apostol Andrei" Emergency County Hospital, 900591 Constanta, Romania.
Luana Andreea BoșoteanuInstitute of Doctoral Studies, School of Medicine, "Ovidius" University of Constanta, 900573 Constanta, Romania.
Ovidius University · ROClinical Emergency Hospital Bucharest · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: A malignant gastrointestinal neuroectodermal tumor (GNET) is an ultra-rare primary neoplasm with a distinctive histopathological, immunohistochemical, molecular, and ultramicroscopic profile, synonymous terminology with clear cell sarcoma-like tumor of the gastrointestinal tract. This case report aims to describe a case of GNET with challenging mesenchymal, lymphoid, and melanic tumor differential diagnosis. (2) Case presentation: We discuss the case of a 67-year-old male patient who presented with diffuse abdominal pain, intermittent lack of intestinal transit, and frequent episodes of nausea, followed by segmental resection of the jejunum and sigmoid colon. The patient had no relevant medical history. The surgical specimen underwent immunohistochemical staining and morphological evaluation. (3) Results: Histopathological analysis reveals a moderately homogeneous polyhedral-epithelioid and spindle cell neoplastic proliferation with a zonal discohesive pattern and extensive and focal fasciculated architecture. Twenty monoclonal antibodies were used for immunostaining, which allowed GNET to be diagnosed on the basis of the tumoral immune profile, characterized by positive reactivity of S100, SOX10, and CD 56. (4) Conclusions: The poor prognosis of GNET is highlighted in the present study, along with the vital importance of differential diagnosis issues with mesenchymal, lymphoid, and melanic tumors, which make the diagnosis difficult for both pathologists and clinicians.

Indexed as

clear celldiagnosis differentialgastrointestinal neoplasmsneuroectodermal tumorssarcoma

Identifiers

PMID36980439
PMCPMC10047330
OpenAlexW4327715111

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read14
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.